Pasar al contenido principal

NUEVOS AGENTES ANTIBACTERIANOS DE PRECISION Y TERAPIAS COMBINADAS PARA COMBATIR INFECCIONES MULTIRRESISTENTES

PID2022-136963OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antimicrobial activity of essential oil components against Escherichia coli depends on the food components present in a food matrix

  • Gómez-Llorente, Héctor|||0000-0001-5968-6041
  • Pérez-Esteve, Édgar|||0000-0002-0452-1394
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Fernández Segovia, Isabel|||0000-0002-7641-2680
  • González-Bello, Concepción
[EN] Despite numerous studies evaluating the antimicrobial activity of essential oil components (EOCs) against different microorganisms, the effect of the composition of the matrix in which they are applied remains unexplored. Hence, the effect of different food components (i.e., proteins, lipids, carbohydrates, acids, ethanol) on vanillin antimicrobial activity was carried out by assessing the growth of E. coli at different incubation times (0, 1, 4, 8 and 24 h). Based on these outcomes, the food components that most adversely affected vanillin antimicrobial activity were subsequently tested with four other EOCs (i.e., carvacrol, eugenol, geraniol, thymol). The effective concentration of antimicrobials after coming into contact with food components was quantified. The results indicated that bovine serum albumin (BSA), sunflower oil and carbohydrates partially or completely inhibited the antimicrobial efficacy of the tested EOCs, and the inhibition rate depended on the specific EOC-food component combination. Geraniol was notably the most efficient with BSA present. Eugenol performed best with sunflower oil. Carvacrol, eugenol, geraniol and thymol were more effective than vanillin with D-lactose present. This study confirmed that loss of EOCs' effective concentration due to an interaction with food constituents is a significant cause of antimicrobial activity inhibition. These findings underscore the importance of considering matrix composition when selecting antimicrobials to combat a particular strain in real food applications., The authors gratefully acknowledge the financial support from the project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe". This work is also granted by the project TED2021-132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by "European Union NextGenerationEU/PRTR". CG-B thanks the financial support received from the Spanish State Agency of Research (PID2022-136963OB-I00/AEI/10.13039/501100011033) , the Xunta de Galicia [ED431C 2021/29 and Centro singular de investigacion de Galicia accreditation 2023-2027 (ED431G 2023/03) ], and the European Regional Development Fund (ERDF). H.G.LL. acknowledges the Universitat Politecnica de Valencia for his predoctoral fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

New Strategies to Enhance the Quality and Safety of Liquid Foods Based on the Use of Natural Antimicrobial Compounds

  • Gómez-Llorente, Héctor|||0000-0001-5968-6041
[ES] Los componentes de los aceites esenciales (CAEs) han demostrado ser eficaces contra una amplia variedad de microorganismos. Sin embargo, su aplicación plantea desafíos debido a su baja solubilidad y alteración de las propiedades organolépticas en los alimentos. Por tanto, la búsqueda de nuevas formas de dosificación es fundamental para promover su uso en la industria alimentaria. La presente tesis doctoral está centrada en el desarrollo y aplicación de sistemas antibacterianos y antivirales basados en la inmovilización covalente de CAEs para mejorar la calidad y seguridad de alimentos líquidos. El primer capítulo evaluó el efecto de la adición de componentes naturalmente presentes en los alimentos (proteínas, lípidos, carbohidratos, ácidos orgánicos y etanol) sobre la actividad antimicrobiana de diferentes CAEs (carvacrol, eugenol, geraniol, timol y vainillina) en su forma libre. Además, se evaluó la influencia de los componentes alimentarios sobre la vainillina inmovilizada. Los resultados mostraron que la albúmina sérica bovina (BSA), el aceite de girasol y algunos carbohidratos fueron los componentes que más inhibieron la actividad antimicrobiana de los CAEs libres, con algunas excepciones. En los medios que contienen BSA, no se inhibió la actividad antimicrobiana del geraniol. Lo mismo ocurrió con eugenol en aceite de girasol, o con carvacrol, eugenol, geraniol y timol en presencia de D-lactosa. La vainillina inmovilizada confirmó el efecto inhibidor de las proteínas, lípidos y carbohidratos sobre la actividad antimicrobiana, pero el ácido cítrico y el etanol mejoraron la actividad antimicrobiana. Estos resultados demuestran la importancia de considerar la composición de la matriz alimentaria al seleccionar un compuesto antimicrobiano. El segundo capítulo evaluó la aplicación de CAEs frente al crecimiento y producción de guaiacol por un microorganismo alterante y termorresistente como Alyciclobacillus acidoterrestris en zumo de naranja. Para ello, se utilizaron CAEs inmovilizados con dos enfoques diferentes: como aditivos y como coadyuvantes tecnológicos. La presencia de CAEs provocó una reducción microbiana y una inhibición de la producción de guayacol, que fue mantenida tras la inmovilización. Este hecho es de gran interés, ya que la inmovilización evita el problema de alteración organoléptica del producto, derivado de la aplicación de estos antimicrobianos en forma libre. En el tercer capítulo se estudió la actividad antiviral de los CAEs, tanto en forma libre como inmovilizada, frente al virus Tulane en agua. La aplicación de CAEs en forma libre logró una reducción de la infectividad de sólo 1 log10, mientras que concentraciones equivalentes de antimicrobiano inmovilizado redujeron la infectividad a más de 4,5 log10. Por otro lado, el mecanismo antiviral se basó en la modificación o alteración de cápside viral. Además, se determinó que los CAEs inmovilizados no son citotóxicos en concentraciones antivirales efectivas. A pesar de la eficacia observada tras la inmovilización de los CAEs, su aplicación práctica en la industria alimentaria presenta varios desafíos, siendo uno de ellos la aceptación de esta tecnología por parte de los consumidores. El último capítulo estudió la percepción de los consumidores sobre el uso de la nanotecnología en el procesamiento de alimentos. La valoración de los distintos alimentos en los que se había aplicado nanotecnología en su procesamiento o envasado fue en general positiva. De todos los productos, aquellos en los que la nanotecnología no formaba parte de los alimentos recibieron la mejor valoración. Teniendo en cuenta este resultado, los CAEs inmovilizados aplicados como coadyuvantes tecnológicos serían los más valorados y, por tanto, podrían ser una excelente alternativa a los tratamientos de conservación convencionales, para controlar tanto virus como bacterias durante la producción y el almacenamiento de alimentos., [CA] Els components dels olis essencials (COEs) han demostrat ser eficaços en fornt d'una àmplia varietat de microorganismes. Tot i això, la seua aplicació planteja desafiaments a causa de la seua baixa solubilitat i alteració de les propietats organolèptiques en els aliments. Per tant, la recerca de noves formes de dosificació és fonamental per promoure'n l'ús a la indústria alimentària. Aquesta tesi doctoral està centrada en el desenvolupament i l'aplicació de sistemes antibacterians i antivirals basats en la immobilització covalent de COEs per a millorar la qualitat i la seguretat d'aliments líquids. El primer capítol va avaluar l'efecte de l'addició de components naturalment presents als aliments (proteïnes, lípids, carbohidrats, àcids orgànics i etanol) sobre l'activitat antimicrobiana de diferents COEs (carvacrol, eugenol, geraniol, timol i vainillina) en la seua forma lliure. En aquesta primera part també es va avaluar la influencia dels components alimentaris sobre la vainillina immobilitzada. Els resultats van mostrar que l'albúmina sèrica bovina (BSA), l'oli de gira-sol i alguns carbohidrats van ser els components que van inhibir més l'activitat antimicrobiana dels COEs lliures, amb algunes excepcions. Als mitjans que contenen BSA no es va inhibir l'activitat antimicrobiana del geraniol. El mateix va passar amb eugenol en oli de gira-sol, o amb carvacrol, eugenol, geraniol i timol en presencia de D-lactosa. La vainillina immobilitzada va confirmar l'efecte inhibidor de les proteïnes, els lípids i els carbohidrats sobre l'activitat antimicrobiana, però l'àcid cítric i l'etanol van millorar l'activitat antimicrobiana. Aquests resultats demostren la importància de considerar la composició de la matriu alimentària quan s'ha de seleccionar un compost antimicrobià per a una aplicació concreta. El segon capítol va avaluar l'aplicació de COEs en front del creixement i la producció de guaiacol per un microorganisme alterant i termorresistent com Alyciclobacillus acidoterrestris en suc de taronja. Per això, es van utilitzar COEs immobilitzats amb dos enfocaments diferents: com a additius i com a coadjuvants. La presència de COEs provoca una reducció microbiana i una inhibició de la producció de guaiacol, així com manté la seua eficàcia després de la immobilització. Aquest fet és de gran interès, ja que la immobilització evita el problema d'alteració organolèptica del producte, derivat de l'aplicació d'aquests antimicrobians en forma lliure. Al tercer capítol es va estudiar l'activitat antiviral dels COEs, tant en forma lliure com immobilitzada, davant del virus Tulane en aigua. L'aplicació de COEs en forma lliure va aconseguir una reducció de la infectivitat de només 1 log10, mentre que concentracions equivalents d'antimicrobià immobilitzat van reduir la infectivitat a més de 4,5 log10. D'altra banda, es va comprobar que el mecanisme antiviral es va basar en la modificació o alteració de la càpside viral. A més, es va determinar que els COEs immobilitzats no són citotòxics en concentracions antivirals efectives. Tot i l'eficàcia observada després de la immobilització dels COEs, la seua aplicació pràctica a la indústria alimentària presenta diversos desafiaments, un dels quals és l'acceptació d'questa tecnologia per part dels consumidors. El darrer capítol va estudiar la percepció dels consumidors sobre l'ús de la nanotecnologia en el processament d'aliments. La valoració dels diferents aliments en que s'havia aplicat nanotecnologia al seu processament o envasat va ser en general positiva. De tots els productes, aquells en que la nanotecnologia no formava part dels aliments van rebre la millor valoració. Tenint en compte aquest resultat, els COEs immobilitzats aplicats com a coadjuvants de processament serien els més valorats i, per tant, podrien ser una alternativa excel·lent als tractaments de conservació convencionals, per controlar tant virus com bacteris durant la producció i l'emmagatzematge d'aliments., [EN] Essential oil components (EOCs) have proven to be effective against a wide variety of microorganisms. However, the direct application of these compounds poses challenges due to their low solubility and alteration of the organoleptic properties of foods. Therefore, the search for new dosage forms of these promising antimicrobials is essential to promote their use in the food industry. The present doctoral thesis is focused on the development and application of antibacterial and antiviral systems based on the covalent immobilization of EOCs to improve the quality and safety of liquid foods. The first chapter evaluated the effect of the addition of components naturally present in food (proteins, lipids, carbohydrates, organic acids and ethanol) on the antimicrobial activity of certain EOCs (carvacrol, eugenol, geraniol, thymol and vanillin) in their free form. In this first part, the influence of these food components on the antimicrobial activity of vanillin immobilized on silicon oxide particles was also evaluated. The results showed that bovine serum albumin (BSA), sunflower oil and some carbohydrates were the food components that most inhibited the antimicrobial activity of the free EOCs, with some exceptions. In media containing BSA the antimicrobial activity of geraniol was not inhibited. The same occurred with eugenol in media containing sunflower oil, or with carvacrol, eugenol, geraniol and thymol in media with D-lactose. Immobilized vanillin confirmed the inhibitory effect of the proteins, lipids and carbohydrates on the antimicrobial activity, but citric acid and ethanol enhanced the antimicrobial activity. These results demonstrate the importance of considering the composition of the food matrix when selecting an antimicrobial compound. The second chapter evaluated the application of EOCs against the growth and production of guaiacol by a spoilage and heat-resistant microorganism such as Alyciclobacillus acidoterrestris in orange juice. For this purpose, EOCs immobilized on silicon oxide particles were used with two different approaches: as additives and as processing aids. The presence of EOCs causes a microbial reduction and an inhibition of guaiacol production, maintaining their effectiveness after immobilization. This fact is of great interest, since immobilization avoids the problem of organoleptic alteration of the product, derived from the application of these antimicrobials in free form. In the third chapter, the antiviral activity of EOCs, both in free and immobilized form, against Tulane virus in water was studied. The application of EOCs in free form achieved a reduction in infectivity of only 1 log10, equivalent concentrations of immobilized antimicrobial reduced infectivity to more than 4.5 log10. On the other hand, it has been demonstrated that the antiviral mechanism is based on the ability of immobilized antimicrobials to modify or disrupt the viral capsid. Furthermore, it was determined that immobilized EOCs are not cytotoxic at effective antiviral concentrations. Despite the efficacy observed after immobilization of EOCs against bacteria and viruses, their practical application in the food industry presents several challenges, one of them is the acceptance of this technology by consumers. Thus, the last chapter studied the perception of consumers regarding the use of nanotechnology in food processing. The evaluation of the different foods in which nanotechnology had been applied in their processing or packaging was generally positive, and most consumers would buy them. Of all the products, those in which nanotechnology was not part of the food received the best evaluation. Considering this result, immobilized EOCs applied as processing aids would be the most highly valued, and therefore could be an excellent alternative to conventional preservation treatments, to control both viruses and bacteria during food production and storage., This research forms part of project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. H.G.LL. acknowledges the Universitat Politécnica de València for his predoctoral fellowship. The authors acknowledge native English translator Helen Warburton for editing the text. The authors gratefully acknowledge the financial support from the project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work is also granted by the project TED2021- 132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”. CG-B thanks the financial support received from the Spanish State Agency of Research (PID2022-136963OBI00/AEI/10.13039/501100011033), the Xunta de Galicia [ED431C 2021/29 and Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03)], and the European Regional Development Fund (ERDF). H.G.LL. acknowledges the Universitat Politècnica de València for his predoctoral fellowship. The authors gratefully acknowledge the financial support from the project PID2021- 128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work is also granted by the project TED2021-132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”. H.G.LL. acknowledges the Universitat Politècnica de València for his predoctoral fellowship.The authors gratefully acknowledge the financial support for the experiment reported herein from the Spanish Government (RTI2018-101599-B-C21-AR). Héctor Gómez Llorente wishes to thank the Universitat Politècnica de València for the FPI Grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins

  • Tamarit-Mayo, Lorena
  • Andreu, Inmaculada|||0000-0003-3409-9443
  • Vayá Pérez, Ignacio|||0000-0003-1682-9342
  • El Ouardi, Meryem
  • Lence, Emilio
  • González-Bello, Concepción
  • Miranda Alonso, Miguel Ángel
[EN] The photobiological damage that certain drugs or their metabolites can photosensitize in proteins is generally associated with the nature of the excited species that are generated upon interaction with UVA light. In this regard, the photoinduced damage of the anticancer drug gefitinib (GFT) and its two main photoactive metabolites GFT-M1 and GFT-M2 in cellular milieu was recently investigated. With this background, the photophysical properties of both the drug and its metabolites have now been studied in the presence of the two main transport proteins of human plasma, i.e., serum albumin (HSA) and ¿1-acid glycoprotein (HAG) upon UVA light excitation. In general, the observed photobehavior was strongly affected by the confined environment provided by the protein. Thus, GFT-M1 (which exhibits the highest phototoxicity) showed the highest fluorescence yield arising from long-lived HSA-bound phenolate-like excited species. Conversely, locally excited (LE) states were formed within HAG, resulting in lower fluorescence yields. The reserve was true for GFT-M2, which despite being also a phenol, led mainly to formation of LE states within HSA, and phenolate-like species (with a minor contribution of LE) inside HAG. Finally, the parent drug GFT, which is known to form LE states within HSA, exhibited a parallel behavior in the two proteins. In addition, determination of the association constants by both absorption and emission spectroscopy revealed that the two metabolites bind stronger to HSA than the parent drug, whereas smaller differences were observed for HAG. This was further confirmed by studying the competing interactions between GFT or its metabolites with the two proteins using fluorescence measurements. These above experimental findings were satisfactorily correlated with the results obtained by means of molecular dynamics (MD) simulations, which revealed the high affinity binding sites, the strength of interactions and the involved amino acid residues. In general, the differences observed in the photobehavior of the drug and its two photoactive metabolites in protein media are consistent with their relative photosensitizing potentials., The Ministry of Science, Innovation and Universities of Spain, the Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital, the University of Valencia, the Health Research Institute Hospital La Fe (IIS La Fe) and La Xunta de Galicia are gratefully acknowledged for financial support. All authors are grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae computer.The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Grants PID2020-115010RB-I00 and PID2022-136963OB-I00 funded by MCIN/AEI/10.13039/501100011033, grant CIAICO/2021/061 funded by Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital and grant AP2022-5 funded by Programa d'Accions Preparatories UV-La Fe. Grants from the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigacion de Galicia accreditation 2019-2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Zwitterionic penicillin-derived sulfone inhibitor for combating β-lactamase-mediated antibiotic resistance

  • Rodríguez Lema, Diana
  • Lence Quintana, Emilio José
  • Vázquez Ucha, Juan Carlos
  • Beceiro Casas, Alejandro
  • González Bello, Concepción
β-Lactam antibiotics, which account for nearly 70% of all prescriptions for bacterial infections, remain the cornerstone of antimicrobial chemotherapy. However, their clinical effectiveness is increasingly compromised by the widespread emergence of β-lactamase-mediated resistance. These enzymes hydrolyze the β-lactam ring through an addition–elimination mechanism, abolishing antibacterial activity. Preserving the efficacy of β-lactam antibiotics, particularly carbapenems, regarded as the last line of defense against multidrug-resistant (MDR) pathogens, is therefore critical. Here, we report the design and synthesis of compound 3, a zwitterionic penicillin-derived sulfone that integrates two key principles: enhanced permeability of zwitterionic molecules and improved inhibitory potency through (2-pyridyl)methylene introduction within the sulbactam scaffold to achieve an adduct stable against hydrolysis. In vitro assays demonstrated that compound 3 significantly restored β-lactam activity against MDR pathogens producing extended-spectrum β-lactamases (ESBLs) and carbapenem-hydrolyzing class D β-lactamases. It notably improved imipenem and ceftazidime efficacy against strains expressing OXA-48 and PDC-1, whose inhibitory capacity was determined by kinetic analysis with the isolated enzymes. Mechanistic studies using mass spectrometry and molecular dynamics simulations revealed ligand-induced pocket formation, π-stacking modulation, and hydrophobic engagement, supporting a covalent, water-shielded inactivation pathway via indolizine adduct formation. The nonsterically hindered amine in 3 favored PDC-1 binding and overall permeability while exerting a neutral effect on OXA-48 binding. These results underscore the potential of compound 3 as a next-generation β-lactamase inhibitor for combating infections caused by ESBL- and carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine

  • Bouzada Reboredo, David
  • Paul, Ananya
  • Sánchez López, Mateo Isidro
  • Domínguez-Asenjo, Bárbara
  • Lence Quintana, Emilio José
  • Melle-Franco, Manuel
  • Ardá, Ana
  • Barreiro Piñeiro, Natalia
  • Penas, Cristina
  • Gómez González, Jacobo
  • Jiménez-Barbero, Jesús
  • Moreno, Javier
  • González Bello, Concepción
  • Wilson, W. David
  • Mascareñas Cid, José Luis
  • Vázquez Sentís, Marco Eugenio
A bisbenzamidine DNA binding agent can be easily dimerized by alkylation of its terminal amidine groups to afford an extended minor groove binder with over 20-fold enhanced DNA affinity toward extended A/T-rich sites. Nuclear magnetic resonance experiments in combination with molecular dynamics simulation studies provide structural insight into the insertion of this compound in the DNA minor groove, and antimicrobial assays demonstrate that the increased affinity translates into higher antileishmanial activity.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Chemical sensors for the early diagnosis of bacterial resistance to β-lactam antibiotics

  • Canabal Falcón, Rafael
  • González Bello, Concepción
β-Lactamases are bacterial enzymes that inactivate β-lactam antibiotics and, as such, are the most prevalent cause of antibiotic resistance in Gram-negative bacteria. The ever-increasing production and worldwide dissemination of bacterial strains producing carbapenemases is currently a global health concern. These enzymes catalyze the hydrolysis of carbapenems – the β-lactam antibiotics with the broadest spectrum of activity that are often considered as drugs of last resort. The incidence of carbapenem-resistant pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii and carbapenemase or extended spectrum beta-lactamase (ESBL)-producing Enterobacterales, which are frequent in clinical settings, is worrisome since, in some cases, no therapies are available. These include all metallo-β-lactamases (VIM, IMP, NDM, SMP, and L1), and serine-carbapenemases of classes A (KPC, SME, IMI, and GES), and of classes D (OXA-23, OXA-24/40, OXA-48 and OXA-58). Consequently, the early diagnosis of bacterial strains harboring carbapenemases is a pivotal task in clinical microbiology in order to track antibiotic bacterial resistance and to improve the worldwide management of infectious diseases. Recent research efforts on the development of chromogenic and fluorescent chemical sensors for the specific and sensitive detection and quantification of β-lactamase production in multidrug-resistant pathogens are summarized herein. Studies to circumvent the main limitations of the phenotypic and molecular methods are discussed. Recently reported chromogenic and fluorogenic cephalosporin- and carbapenem-based β-lactamase substrates will be reviewed as alternative options to the currently available nitrocefin and related compounds, a chromogenic cephalosporin-based reagent widely used in clinical microbiology laboratories. The scope of these new chemical sensors, along with the synthetic approaches to synthesize them, is also summarized
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors

  • Outeda García, Michelle
  • Lence Quintana, Emilio José
  • González Bello, Concepción
  • Beceiro, Alejandro
Carbapenemase OXA-48 and its variants pose a serious threat to the development of effective effective effective treatments for bacterial infections. OXA-48-producing Enterobacterales are the most prevalent carbapenemase-producing bacteria in large parts of the world. Although these bacteria exhibit low-level carbapenem resistance in vitro, the infections they cause are challenging to treat with conventional therapies, owing to their spread and complex detection in clinical settings. However, numerous β-lactamase inhibitors (BLIs) are currently in the pipeline or late clinical stages. To assess the potential of these compounds, this study compared the efficacy efficacy against OXA-48 of novel β-lactamase inhibitors, specifically the 1,6-diazabicyclo[3,2,1]octanes (DBOs) avibactam, relebactam, zidebactam, nacubactam, and durlobactam, along with the cyclic and bicyclic boronates vaborbactam, taniborbactam, and xeruborbactam. The extensive kinetics assays identified identified xeruborbactam, taniborbactam, and durlobactam, together with the already established avibactam, as BLIs with superior biochemical performance. Susceptibility testing further validated these findings but also demonstrated significantly significantly significantlysignificantlyimproved bacterial killing by the DBOs zidebactam, nacubactam, and durlobactam. On the other hand, binding studies demonstrated the superior inhibitory capacity of the BLIs durlobactam and xeruborbactam. Combinations, such as cefepime/zidebactam, meropenem/nacubactam, and sulbactam/durlobactam, show promising activity against OXA-48-producing Enterobacterales, while ceftazidime/avibactam, cefepime/taniborbactam, and meropenem/xeruborbactam combinations also appear highly active, largely due to the excellent kinetics of these new inhibitors. Overall, this comprehensive analysis provides important insights into the effectiveness effectiveness effectiveness of new BLIs against OXA-48-producing Enterobacterales, highlighting xeruborbactam, durlobactam, and avibactam as leading candidates. Additionally, BLIs like zidebactam, nacubactam, and taniborbactam also showed potential in addressing the clinical challenges posed by OXA-48-mediated antimicrobial resistance.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Novel antimicrobial self-assembled cyclic peptide nanotubes containing (1R,3S,4R,5R)-3-amino-4,5-dihydroxycyclohexane-1-carboxylic acid, a new building block for developing mimetics of saccharide–peptide hybrids

  • González Freire, Eva
  • Vilela Picos, Marcos
  • Prado López, Verónica
  • Pérez Estévez, Antonio
  • Seoane Prado, Rafael
  • Amorín López, Manuel
  • González Bello, Concepción
  • Granja Guillán, Juan Ramón
A new class of supramolecular antimicrobials based on D,L-cyclic peptides containing a dihydroxylated-γ-residue, which was designed to mimic the saccharide component present in certain carbohydrate–peptide hybrids, is described. The fully protected amino acid was prepared from shikimic acid and incorporated into clickable amphipathic cyclic peptides. The resulting peptides self-assemble into nanotubes that interact with bacterial membranes, ultimately causing cell death. Notably, the incorporation of this new residue not only retains antimicrobial activity but also significantly reduces toxicity in mammalian cells, thereby broadening the therapeutic window of these peptides.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Antimicrobial activity of essential oil components against Escherichia coli depends on the food components present in a food matrix

  • Gómez-Llorente, Héctor
  • Pérez-Esteve, Édgar
  • Barat, José M.
  • Jiménez, M. Consuelo
  • González Bello, Concepción
  • Fernández-Segovia, Isabel
Despite numerous studies evaluating the antimicrobial activity of essential oil components (EOCs) against different microorganisms, the effect of the composition of the matrix in which they are applied remains unexplored. Hence, the effect of different food components (i.e., proteins, lipids, carbohydrates, acids, ethanol) on vanillin antimicrobial activity was carried out by assessing the growth of E. coli at different incubation times (0, 1, 4, 8 and 24 h). Based on these outcomes, the food components that most adversely affected vanillin antimicrobial activity were subsequently tested with four other EOCs (i.e., carvacrol, eugenol, geraniol, thymol). The effective concentration of antimicrobials after coming into contact with food components was quantified. The results indicated that bovine serum albumin (BSA), sunflower oil and carbohydrates partially or completely inhibited the antimicrobial efficacy of the tested EOCs, and the inhibition rate depended on the specific EOC-food component combination. Geraniol was notably the most efficient with BSA present. Eugenol performed best with sunflower oil. Carvacrol, eugenol, geraniol and thymol were more effective than vanillin with D-lactose present. This study confirmed that loss of EOCs’ effective concentration due to an interaction with food constituents is a significant cause of antimicrobial activity inhibition. These findings underscore the importance of considering matrix composition when selecting antimicrobials to combat a particular strain in real food applications.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins

  • Tamarit, Lorena
  • El Ouardi, Meryem
  • Lence, Emilio
  • Andreu, Inmaculada
  • González-Bello, Concepción
  • Miranda, M. A.
  • Vayá, Ignacio
The photobiological damage that certain drugs or their metabolites can photosensitize in proteins is generally associated with the nature of the excited species that are generated upon interaction with UVA light. In this regard, the photoinduced damage of the anticancer drug gefitinib (GFT) and its two main photoactive metabolites GFT-M1 and GFT-M2 in cellular milieu was recently investigated. With this background, the photophysical properties of both the drug and its metabolites have now been studied in the presence of the two main transport proteins of human plasma, i.e., serum albumin (HSA) and α1-acid glycoprotein (HAG) upon UVA light excitation. In general, the observed photobehavior was strongly affected by the confined environment provided by the protein. Thus, GFT-M1 (which exhibits the highest phototoxicity) showed the highest fluorescence yield arising from long-lived HSA-bound phenolate-like excited species. Conversely, locally excited (LE) states were formed within HAG, resulting in lower fluorescence yields. The reserve was true for GFT-M2, which despite being also a phenol, led mainly to formation of LE states within HSA, and phenolate-like species (with a minor contribution of LE) inside HAG. Finally, the parent drug GFT, which is known to form LE states within HSA, exhibited a parallel behavior in the two proteins. In addition, determination of the association constants by both absorption and emission spectroscopy revealed that the two metabolites bind stronger to HSA than the parent drug, whereas smaller differences were observed for HAG. This was further confirmed by studying the competing interactions between GFT or its metabolites with the two proteins using fluorescence measurements. These above experimental findings were satisfactorily correlated with the results obtained by means of molecular dynamics (MD) simulations, which revealed the high affinity binding sites, the strength of interactions and the involved amino acid residues. In general, the differences observed in the photobehavior of the drug and its two photoactive metabolites in protein media are consistent with their relative photosensitizing potentials., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Grants PID2020-115010RB-I00 and PID2022-136963OB-I00 funded by MCIN/AEI/10.13039/501100011033, grant CIAICO/2021/061 funded by Conselleria d’Innovació, Universitats, Ciència i Societat Digital and grant AP2022-5 funded by Programa d'Accions Preparatòries UV-La Fe. Grants from the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF).